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ABSTRACT
To determine the prophylactic effects of lotus plumule (Nelumbo nucifera Geartn.) supplementation in vivo on acute systemic
inflammation, the mediators secreted in serum and by cultured peritoneal macrophages from the lipopolysaccharide (LPS)-challenged mice were measured. The female BALB/c mice were continuously supplemented with lotus plumule for 3 weeks and
then administrated with an intra-peritoneal (i.p.) LPS injection at a concentration of 10 mg/kg body weight (BW) to induce acute
systemic inflammation. After 24 hours of LPS injection, the mice were sacrificed to determine the inflammatory mediators. The
results showed that high dose supplementation (20 mg/day/mouse) with lotus plumule significantly (P < 0.05) decreased the proinflammatory cytokine of tumor necrosis factor-α (TNF-α) level in the serum of LPS-challenged mice. Simultaneously, supplementation with lotus plumule significantly increased the levels of anti-inflammatory cytokine IL-10 produced by peritoneal macrophages from LPS-challenged mice. The results indicated that lotus plumule supplementation significantly inhibited the production
of pro-inflammatory cytokine TNF-α and increased that of anti-inflammatory cytokine IL-10. It can be concluded that lotus
plumule supplementation before systemic inflammation attenuates the acute inflammation status in vivo.
Key words: Lotus plumule, Lipopolysaccharide, Tumor necrosis factor-α (TNF-α), Interleukin-10 (IL-10), Peritoneal macrophages,
Acute inflammation

INTRODUCTION
Lotus (Nelumbo nucifera Geartn.), a southeast Asian
aquatic edible plant, is traditionally used as a Chinese medicine to treat different disorders, particularly inflammation(1).
Lotus seeds are commonly consumed by people in Taiwan.
However, the plumule, a germ of lotus seed, is usually
removed from lotus seeds due to its bitter taste. Lotus seed
plumule is found to have antioxidant activities(2) and is recognized as a “cooling food”(3) with anti-inflammatory activities.
However, the research of lotus plumule against inflammation
in vivo is still limited. In this study, we attempted to determine the effects of lotus plumule supplementation in vivo on
an acute systemic inflammation.
Sepsis is accompanied by severe systemic inf lammation with a high mortality rate of 40~60 percent (4).
The severity of inf lammation may serve as a predictor
for survival and be detected by leukocyte (neutrophil and
monocyte) activation in the circulation and the inf lammator y mediator production during sepsis (5) . Thus,
serum inf lammatory mediators and leukocyte function,
especially monocytes/macrophages play crucial indictors
of systemic inf lammation. TNF-α, IL-1, and IL-6 are
recognized as pro-inf lammatory cytokines (6-7). Nitric
oxide (NO) and prostaglandin E2 (PGE2) produced from
lipopolysaccharide (LPS)-induced inf lammatory cells,
* Author for correspondence. Tel: + 886-4-22851857;
Fax: +886-4-22851857; E-mail: jinlin@nchu.edu.tw.

especially macrophages or chondrocytes, are served as
pro-inflammatory indicators(8) and regarded as secondary
inflammatory mediators(4) during inflammation. However, IL-10 plays an anti-inflammatory cytokine and exhibits its potent anti-inflammatory activities via inhibiting
the synthesis of pro-inflammatory cytokines, the release
of reactive oxygen and nitrogen intermediates, and the
antigen-presenting capacity of mononuclear phagocytes or
dendritic cells(9).
Ancient herbal medicines or medicinal foods might
provide a modern hope for the treatment of sepsis or acute
systemic inflammation. For example Sedum kamtschaticum,
a folk medicine in Northeast Asia for treating inflammatory
disorders, has been reported to inhibit cyclooxygenase-2
expression of LPS-treated RAW 264.7 and demonstrates a
potent anti-inflammatory activity(10). The aqueous extract of
sword brake fern (Pteris ensiformis Burm), a component in
most of the traditional herbal beverage formulas in Taiwan,
attenuates inflammatory mediator (TNF-α, IL-1β, IL-6, NO,
and PGE2) synthesis of activated macrophages (RAW 264.7)
partially through a NF-κB-dependent pathway(11). Lotus
plumule is also traditionally used as an anti-inflammatory
agent in Chinese medicine formulas. In this study, we
investigated the effects of lotus plumule on acute systemic
inflammation in vivo. To evaluate the prophylactic effects
of lotus plumule, female BALB/c mice were consecutively
supplemented with lotus plumule powder through 3 weeks
supplementation before systemic administration of LPS and
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following intra-peritoneal injection of endotoxin LPS. After
LPS challenge for 24 hours, the cytokines and inflammatory mediators in serum and peritoneal macrophage cultures
from the LPS-challenged mice were measured.

MATERIALS AND METHODS
I. Plant Material and Sample Preparation
Fresh lotus seeds from a variety of Nelumbo nucifera
Geartn. were provided by a local farmer in Tainan, Taiwan.
The lotus seeds were harvested in the late summer of 2003.
The lotus plumule was carefully collected and air dried at
40°C oven for one night. Then the air-dried lotus plumule
was milled into powder, sealed in a plastic bottle, and
stored at -20°C until use.
II. Experimental Animals and Dietary Groups
Female BALB/cByJNarl mice (6 weeks old) were
obtained from the National Laboratory Animal Center,
National Applied Research Laboratories, National Science
Council in Taipei, Taiwan and maintained in the Department
of Food Science and Biotechnology at National Chung Hsing
University, College of Agriculture and Natural Resources
in Taichung, Taiwan. The mice were housed and kept on
a chow diet (laboratory standard diet; BioLASCO Taiwan
Co., Ltd.). The animal room was kept on a 12-h-light and
12-h-dark cycle. Constant temperature (25±2°C) and relative humidity (50-60%) were maintained. After the mice
acclimatized for 2 weeks, the mice were divided into four
groups (n = 6) including non-sensitized control (SC, 0 mg
lotus plumule/day/mouse), dietary control (DC, 0 mg lotus
plumule/day/mouse), low dose supplementation group (L, 5
mg lotus plumule/day/mouse), and high dose supplementation group (H, 20 mg lotus plumule/day/mouse). A series
of preliminary experiments were conducted to determine
the effective lotus plumule dosage. To test the prophylactic
effects of lotus plumule on acute systemic inflammation, the
lotus plumule was supplemented daily for 3 weeks with tube
feeding. Aliquots of 0.5 mL double distilled water containing different concentrations of lotus plumule powder were
respectively supplemented to each mouse for 3 consecutive weeks before LPS challenge. Mouse body weight was
measured every 4 days during the study period. No significant difference in body weight was found among the four
groups during the experimental period (data are not shown).
III. Challenge with LPS by Intra-peritoneal (i.p.) Injection
to Induce Acute Systemic Inflammation in a Female BALB/c
Mouse Model
To test the effects of lotus plumule supplementation on
systemic inflammation, the mice (11 weeks old) which had
been supplemented with lotus plumule powder for 3 consecutive weeks were challenged with Escherichia coli LPS

(O127:B8, Sigma-Aldrich Co., L-3129) to establish a systemic inflammation murine model. Mice were given an intraperitoneal injection of LPS from Escherichia coli O127:B8
(Sigma-Aldrich Co., L-3129) at a concentration of 10 mg/kg
body weight (BW). Each animal received this concentration
of LPS in a volume of 100 μL of LPS dissolved in sterilized
phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM
KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2-7.4, 0.2
μm filtered) using aliquots from a single lot of LPS. The
control animals (SC group) received the same volume of
PBS. At 24 hours after injection of LPS, all experimental
animals were sacrificed. The sera and peritoneal macrophages were collected for cytokine assay.
IV. Animal Sample Collection
(I) Serum Collection
At 24 hours after injection of LPS, the animals were
weighed, anaesthetized with a diethyl ether and immediately exsanguinated by retro-orbital venous plexus puncture. The blood was respectively collected into a 1.5 mL
vial, allowed to stand for 2 h at room temperature, and then
centrifuged at 12,000 × g for 15 min at 4°C to separate
the serum. The serum from each mouse was respectively
collected and stored at -70°C for later analysis.
(II) Collection of Peritoneal Macrophage Cell Cultures
Anesthetized mice were exsanguinated before CO2
euthanasia. Peritoneal cells were prepared by lavaging the
peritoneal cavity with 2 aliquots of 5 mL sterile Hank,s
balanced salts solution (HBSS) for a total of 10 mL through
peritoneum. The peritoneal lavage fluid was centrifuged at
200 × g for 10 min at 4°C. The cell pellets were collected
and re-suspended in TCM medium. The peritoneal adherent cells (mostly macrophages) from each animal were
adjusted to 3 × 10 6 cells/mL in TCM medium with a
hemocytometer using trypan blue dye exclusion method.
Peritoneal adherent cells (0.50 mL/well) in the absence or
presence of stimulus (0.50 mL/well, LPS (Sigma-Aldrich
Co., L-2654) at a final concentration of 10 μg/mL) were
plated in 24 well plates. The plates were incubated at 37°C
in a humidified incubator with 5% CO2 and 95% air for 48
hours. The plates were centrifuged at 200 × g for 10 min.
The supernatants in cell cultures were collected and stored
at -70°C for cytokine and inflammatory mediator assays.
V. Analytical Methods
(I) Measurement of Cytokine Levels in Sera and Peritoneal
Cell Cultures by an Enzyme-linked Immunosorbent Assay
(ELISA)
Cytokine (IL-2, IL-6, IL-10, or TNF-α) levels were
determined by sandwich ELISA kits, respectively. The
cytokine concentrations were assayed according to the
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Table 1. Effects of lotus plumule on serum mediator levels from female BALB/c mice after three weeks of consecutive tube feeding and
treatment with lipopolysaccharide i.p. for 24 hours
Serum mediators
groups

IL-2 (pg/mL)

IL-6 (pg/mL)

IL-10 (pg/mL)

NO (μM)

TNF-α (pg/mL)

non-sensitized control group (SC)

353 ± 108

—*

1863 ± 303

18.9 ± 4.8

—*

dietary control group (DC)

444 ± 112

563 ± 211

1321 ± 359

9.8 ± 1.3

14.5 ± 1.1

low dose group (5 mg /mouse/day)

376 ± 139

354 ± 67

743 ± 234

9.8 ± 1.6

9.1 ± 5.9

high dose group (20 mg/mouse/day)

193 ± 74

394 ± 97

640 ± 199

14.8 ± 2.7

—*

Each value represents a mean ± S.E. (n = 6). Asterisk (*) means P < 0.05 vs. dietary control (DC) group in the same column. -: undetectable.

manufacturer’s cytokine ELISA protocol (mouse DuoSet
ELISA Development system, R&D Systems). The sensitivity of these cytokine assays was about 15.6 pg/mL.
(II) Inflammatory Mediator Levels of Nitric Oxide (NO) in
Sera or Peritoneal Macrophage Cell Cultures
Aliquots of 80 μLof samples and standards (0-100
μM sodium nitrite (Sigma-Aldrich Co., S-2252) dissolved
in double distilled water) were pipeted into the 96 microplate wells (Nunc), respectively. Aliquots of 160 μL of
Griess reagent were then added into each respective well to
develop the color. The Griess reagent was freshly prepared
from Reagent A and B at a ratio of 1:1 (Reagent A: 2%
(w/v) sulfanilamide (Sigma-Aldrich Co., S-9251) dissolved
in 2.5% (v/v) phosphoric acid; Reagent B: 0.2% (w/v)
N-1-naphthylethylene diamide dihydrochloride (SigmaAldrich Co., N-9125) dissolved in 2.5% (v/v) phosphoric
acid). After incubation for 10 min, the plate was read on a
plate reader (ELISA reader, ASYS Hitech GmbH, Austria)
at 540 nm. Using the standard curve, the NO concentration for each unknown sample was determined.
VI. Statistical Analysis of Data
Data are expressed as mean ± S.E. and analyzed
statistically using Dunnett’s t-test of parametric type.
Differences between the dietary control and other groups
were considered statistically significant if P < 0.05.

RESULTS
I. Effects of Lotus Plumule Supplementation on Serum
Mediators of LPS-challenged Mice
The serum mediator levels of female BALB/c mice
fed with lotus plumule powder and administrated with
LPS i.p. are shown in Table 1. The results showed that
neither LPS challenge nor lotus plumule supplementation significantly affect the IL-2, IL-10, and NO levels
in the serum. However, lotus plumule supplementation
decreased IL-2 (from 444 ± 112 to 193 ± 74 pg/mL) and
IL-10 (from 1321 ± 359 to 640 ± 119 pg/mL) levels in the
sera of LPS-challenged mice. The levels of serum IL-6

and TNF-α are too low to be detectable in the non-sensitized control group (SC group). Predictably, the serum
levels of IL-6 (from 0 to 563 ± 211 pg/mL) and TNF-α
(from 0 to 14.5 ± 1.1 pg/mL) from LPS-challenged mice
increased. Supplementation with lotus plumule decreased
serum IL-6 (from 563 ± 211 to 394 ± 97 pg/mL) levels of
LPS-challenged mice, but it did not reach statistical significance at the dosage used in this study. Lotus plumule
supplementation decreased the levels of serum TNF-α
in a dose-dependent manner, while supplemented with
high dose significantly inhibited the production of serum
TNF-α (from 14.5 ± 1.1 to 0 pg/mL) in LPS-challenged
mice. Closer inspection of the data indicated that TNF-α
levels in serum were lower than that of the ELISA kit
sensitivity (15.6 pg/mL). The low TNF-α level in serum
suggests that LPS challenge resulted in sub-septic rather
than septic inf lammation in this study. Simultaneously,
low level of cytokine might result in experimental deviation.
II. Effects of Lotus Plumule Supplementation on the
Levels of IL-10 in Peritoneal Macrophage Cultures from
LPS-challenged mice
To investigate the anti-inflammatory effects of lotus
plumule supplementation in vivo on the peritoneal macrophages, the anti-inf lammatory cytokine IL-10 levels in
peritoneal macrophage cultures from LPS-challenged
mice were determined (Figure 1). The peritoneal macrophages were cultured in the absence (spontaneous) and
presence of stimulus (LPS-stimulated). Figure 1 shows
that LPS challenge did not significantly affect spontaneous
and LPS-stimulated IL-10 levels in peritoneal macrophage
cultures. However, lotus plumule supplementation significantly increased the levels of spontaneous and LPS-stimulated IL-10 (from 0 to 387 ± 75 pg/106 cells; from 8.6 ± 4.3
to 558 ± 136 pg/106 cells, respectively) secreted by peritoneal exudate cells.
III. Effects of Lotus Plumule Supplementation on the Level
of IL-6 in Peritoneal Macrophage Cultures from LPS-challenged Mice
To evaluate the effects of lotus plumule supplementation on the cytokine secretions of macrophages, the amounts

276
Journal of Food and Drug Analysis, Vol. 14, No. 3, 2006

To further investigate the effects of lotus plumule
supplementation on the peritoneal macrophages, the levels
of pro-inf lammatory mediator NO in peritoneal macrophage cultures from LPS-challenged mice were determined (Figure 3). The results showed that LPS challenge
increased spontaneous and LPS-stimulated NO production
from 2.42 ± 1.89 to 2.74 ± 1.03 n mole/106 cells and from
0.98 ± 0.34 to 11.5 ± 5.4 n mole/106 cells, respectively, in
peritoneal macrophage cultures. Lotus plumule supplementation decreased LPS-stimulated NO levels from 11.5
± 5.4 to 3.51 ± 1.78 n mole/106 cells in a dose-dependent
manner in the peritoneal macrophage cultures from
LPS-challenged mice. However it did not significantly
decrease the levels of NO.

DISCUSSION
Severe sepsis may not be reversible and generally
result in high mortality. In this study, we established
a mild systemic inf lammation model, in which female
BALB/c mice were challenged i.p. by a single dose of
10 mg LPS/kg BW. According to our preliminary data,
the LPS-challenged mice were sick from LPS challenge,
but none died during one week of observation period.
A sub-lethal endotoxic shock murine model has been
established. The sub-septic doses of endotoxin LPS can
activate distinct immune responses, such as systemic
inflammation, and have been used in previous studies for
different purposes(12-14). Using our established sub-septic
(sub-lethal) animal model, the effects of lotus plumule
supplementation in vivo on acute systemic inflammation
were measured. The results showed that LPS challenge
(DC group) significantly increased serum mediator levels
of IL-6 or TNF-α, suggesting that systemic inflammation
was induced. Supplementation with lotus plumule daily
before systemic inflammation decreased serum IL-6 levels
of LPS-challenged mice and decreased pro-inflammatory
cytokine TNF-α levels in serum in a dose-dependent
manner (Table 1). IL-6 plays a critical role in the manifestation of fever and is believed to be a pro-inflammatory

*

IL-10 production of peritoneal cells (pg/106 cells)

IV. Effects of Lotus Plumule Supplementation on the Levels
of NO in Peritoneal Macrophage Cultures from LPS-challenged Mice

cytokine (7). TNF-α, produced by macrophages, natural killer (NK) cells, and T cells, has been suggested to
play an important role in endotoxin-mediated shock and
inflammation(15). The effects on serum mediators suggest
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Figure 1. Effects of lotus plumule on IL-10 production of peritoneal
macrophage cultures from female BALB/c mice after three weeks
of tube feeding and treatment with lipopolysaccharide i.p. for 24
hours. Each value represents mean ± S.E. (n = 6). Asterisk (*) means
P < 0.05 vs. dietary control (DC) group. SC: non-sensitized control
group (0 mg of lotus plumule /mouse/day) ; L: low dose group (5 mg
of lotus plumule/mouse/day); H: high dose group (20 mg of lotus
plumule /mouse/day).
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of IL-6 in peritoneal macrophage cultures were measured
(Figure 2). The results showed that LPS challenge significantly inhibited spontaneous IL-6 production (from 7.43 ±
1.51 to 2.48 ± 1.56 ng/106 cells) of macrophages, suggesting that LPS challenge affected the immune responses of
macrophages. Supplemented with lotus plumule decreased
IL-6 production in a dose-dependent manner in both spontaneous (from 2.48 ± 1.56 to 1.66 ± 1.33 ng/106 cells) and
LPS-stimulated (from 1.10 ±0.10 to 0.71 ± 0.31 ng/106 cells)
macrophage cultures. However it did not reach statistical
significance at the dosage used in this study.
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Figure 2. Effects of lotus plumule on IL-6 production of peritoneal
macrophage cultures from female BALB/c mice after three weeks of
tube feeding and treatment with lipopolysaccharide i.p. for 24 hours.
Each value represents mean ± S.E. (n = 6). Asterisk (*) means P
< 0.05 vs. dietary control (DC) group. SC: non-sensitized control
group (0 mg of lotus plumule /mouse/day); L: low dose group (5
mg of lotus plumule/mouse/day); H: high dose group (20 mg lotus
plumule /mouse/day).
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Figure 3. Effects of lotus plumule on nitric oxide production of
peritoneal macrophage cultures from female BALB/c mice after three
weeks of tube feeding and treatment with lipopolysaccharide i.p. for
24 hours. Each value represents mean ± S.E. (n = 6). No statistical
difference between experimental groups and dietary control groups
(DC). SC: non-sensitized control group (0 mg of lotus plumule /
mouse/day); L: low dose group (5 mg of lotus plumule/mouse/day); H:
high dose group (20 mg of lotus plumule /mouse/day).

that lotus plumule supplementation before acute systemic
inf lammation alleviates acute inf lammation status via
inhibiting serum IL-6 and TNF-α production.
Macrophages are large mononuclear phagocytic cells
involving innate and adaptive immunity in vivo. They are
migratory cells and are found in most tissues of the body.
The releases of IL-1, IL-6, and TNF-α by macrophages
may induce local protective effects, but they can have
damaging effects when released systemically. However,
IL-10 produced by T cells and macrophages is a cytokine
synthesis inhibitory factor which might provide host defense
against systemic inflammation. IL-10 reduces the severity
of local and systemic inflammation in a murine model of
intestinal ischemia/reperfusion when given before or after
reperfusion injury. It is suggested that IL-10 may exert antiinflammatory effects via blocking cytokine production and
distant organ neutrophil accumulation(16). Kupffer cellderived IL-10 is also found to play a critical role in host
defense in murine septic peritonitis(9). In this study, lotus
plumule supplementation decreased pro-inf lammatory
mediators IL-6 and NO production in both spontaneous and
LPS-stimulated macrophage cultures in a dose-dependent
manner (Figures 2 and 3). Simultaneously, supplementation with lotus plumule significantly increased the levels of
spontaneous and LPS-stimulated IL-10 (Figure 1). These
results suggest that lotus plumule might demonstrate an
anti-inflammatory effect via enhancing the secretion of antiinflammatory cytokine IL-10 by macrophages. We assumed
that supplemented with low dose of lotus plumule for 3
weeks before LPS challenge administration could stimulate IL-10 production and inhibit TNF-α secretion during
systemic inflammation. These results suggest that supple-

mentation of lotus plumule might exhibit prophylactic effect
on acute systemic inflammation in vivo.
Lotus plumule is traditionally used anti-inflammatory
agent. Lotus seeds were reported to be effective in antioxidant properties and protecting DNA damage in human
lymphocytes in vitro (17-18). Hydro-alcoholic extract of
lotus plumule is found to have heapto- and renal-protective
activities against carbon tetracholoride (CCl4) damage and
demonstrate an antioxidant activity in vivo and in vitro(19).
Liu et al.(20) reported that ethanolic extracts of Nelumbo
nucifera seeds, NN-B-4, suppresses human peripheral
blood mononuclear cells (PMBC) proliferation via inhibiting cyclin-dependent kinase (cdk) 4 mRNA expression. NN-B-4 also suppresses the production and mRNA
expression of IL-2, IL-4, IL-10, and IFN-γ in vitro in
activated PMBC(20). In this study, lotus plumule was first
introduced to treat acute systemic inflammation. Lotus
plumule supplementation decreased serum IL-2, IL-6,
IL-10, and TNF-α levels in LPS-challenged mice (Table 1).
The in vitro and in vivo effects of lotus plumule on serum
cytokine secretion are accordant. However, lotus plumule
supplementation enhanced IL-10 production by peritoneal
macrophages from LPS-challenged mice. The in vivo
effects of lotus plumule on serum and macrophage IL-10
expression seemed not corresponding. We assume different effects of lotus plumule on different cells. The immunomodulatory mechanisms and pharmacological effects of
lotus plumule against systemic inflammation need further
investigation.
Lotus plumule contains alkaloids, saponins, phenolics and carbohydrates (19). Recently, lotus seed extracts
are found to contain phenolics including caffeic acid,
chlorogenic acid, p-hydroxybenzoic acid, gallic acid and
large amounts of phenolic compounds which are suggested
to be responsible for the antioxidant activity(17-18). Three
novel flavonols, myricetin-3,-O-(6,,-p-coumaroyl) glucoside, myricetin-3-O-rhamnoside and pentagalloyl glucose
have been isolated from the wild water lily Nymphaea
lotus L.(21). Dietary isof lavonones including daidzin,
glycitin, and genistin, have been found to suppress
endotoxin-induced inf lammatory reactions in the liver
and intestine (22). We presume that phenolic compounds,
especially flavonoids, in lotus plumule might contribute to
the anti-inflammatory effects against systemic inflammation. However, the effective components of lotus plumule
against systemic inflammation remain to be elucidated.

CONCLUSIONS
This study showed that lotus plumule supplementation
before acute systemic inflammation significantly decreased
serum TNF-α level and increased peritoneal macrophages
derived IL-10 production. These results suggest that lotus
plumule exhibits an anti-inflammatory effect against acute
systemic inf lammation. Lotus plumule can be used to
develop anti-inflammatory agent in the future.
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